FLGT · Fulgent Genetics, Inc.

$18.56 -0.09 (-0.48%) At close · Aug 14

Market Cap

$510.68M

27.52M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ming Hsieh	Chief Executive Officer	$1,000,000	—	$4,000,000	—	$1,207,000	—	$6,207,000
Jian Xie	President and Chief Operating Officer	$615,000	—	$1,845,000	—	$334,037	$13,621	$2,807,658
Paul Kim	Chief Financial Officer	$600,000	—	$1,800,000	—	$325,890	$47,462	$2,773,352
Hanlin Gao	Chief Scientific Officer and Laboratory Director	$513,000	—	$1,539,000	—	$278,636	$21,613	$2,352,249

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ming Hsieh	Chief Executive Officer	$1,000,000	—	$4,000,000	—	$1,128,000	—	$6,128,000
Jian Xie	President and Chief Operating Officer	$615,000	—	$1,537,500	—	$208,116	$15,179	$2,375,795
Paul Kim	Chief Financial Officer	$600,000	—	$1,500,000	—	$203,040	$50,604	$2,353,644
Hanlin Gao	Chief Scientific Officer and Laboratory Director	$513,000	—	$1,282,500	—	$173,599	$12,879	$1,981,978

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ming Hsieh	Chief Executive Officer	$1,000,000	—	$3,000,000	—	$1,309,167	—	$5,309,167
Jian Xie	President and Chief Operating Officer	$615,000	—	$922,500	—	$241,541	$12,200	$1,791,241
Paul Kim	Chief Financial Officer	$600,000	—	$900,000	—	$235,650	$43,963	$1,779,613
Hanlin Gao	Chief Scientific Officer and Laboratory Director	$513,000	—	$769,500	—	$201,481	$6,221	$1,490,202

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ming Hsieh	Chief Executive Officer	$947,917	—	$3,572,400	—	$713,556	—	$5,233,873
Paul Kim	Chief Financial Officer	$579,167	—	$3,115,000	—	$128,440	$49,980	$3,872,587
Jian Xie	President and Chief Operating Officer	$611,875	—	$3,115,000	—	$131,651	$12,200	$3,870,726
Hanlin Gao	Chief Scientific Officer and Laboratory Director	$510,292	—	$3,115,000	—	$109,816	$10,500	$3,745,608

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ming Hsieh	Chief Executive Officer	$664,303	$5,000,000	—	—	—	—	$5,664,303
Hanlin Gao	Chief Scientific Officer and Laboratory Director	$427,262	$200,000	$269,570	—	—	$3,275	$900,107
Han Lin Gao	Chief Scientific Officer and Laboratory Director	$427,262	$200,000	$269,570	—	—	$3,275	$900,107
Jian Xie	President and Chief Operating Officer	$495,920	$200,000	—	—	—	$8,700	$704,620
Paul Kim	Chief Financial Officer	$424,878	$200,000	—	—	—	$45,104	$669,982

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jian Xie	President and Chief Operating Officer	$210,000	$8,000	$5,684,000	—	—	$6,540	$5,908,540
Paul Kim	Chief Financial Officer	$210,000	$8,000	$1,136,800	—	—	$35,656	$1,390,456
Ming Hsieh	Chief Executive Officer	$240,000	$8,000	—	—	—	—	$248,000
Han Lin Gao	Chief Scientific Officer and Laboratory Director	$210,000	$8,000	—	—	—	$5,513	$223,513
Hanlin Gao	Chief Scientific Officer and Laboratory Director	$210,000	$8,000	—	—	—	$5,513	$223,513

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jian Xie	Chief Operating Officer	$205,397	—	$657,400	—	—	$6,162	$868,959
Paul Kim	Chief Financial Officer	$210,000	—	$581,800	—	—	$31,681	$823,481
Han Lin Gao	Chief Scientific Officer and Laboratory Director	$210,000	—	$113,400	—	—	$6,300	$329,700
Ming Hsieh	President and Chief Executive Officer	$240,000	—	—	—	—	—	$240,000

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Kim	Chief Financial Officer	$210,000	—	—	—	—	$31,124	$241,124
Ming Hsieh	President and Chief Executive Officer	$240,000	—	—	—	—	—	$240,000
Han Lin Gao	Chief Scientific Officer and Laboratory Director	$210,000	—	—	—	—	$6,300	$216,300

Executive changes

Person	Role	Change	Effective	Filed
Regina Groves	director	Appointed	2026-05-14	2026-05-14
Michael Nohaile, Ph.D.	director	Appointed	2026-05-14	2026-05-14
Linda Dong	director	Appointed	2026-05-14	2026-05-14
Ming Hsieh	director	Appointed	2026-05-14	2026-05-14
Regina Groves	director	Appointed	2023-05-18	2023-05-18
Linda Marsh	director	Appointed	2023-05-18	2023-05-18
Michael Nohaile	director	Appointed	2023-05-18	2023-05-18
Ming Hsieh	director	Appointed	2023-05-18	2023-05-18
Regina ("Reggie") Groves	member of the Board	Appointed	2023-01-03	2023-01-03
Leonard Post	Board and as the Chair of the Nominating and Corporate Governance Committee of the Board	Resigned	2022-10-31	2022-11-04
John Bolger	Chair of the Audit Committee and member of the Compensation Committee and Nominating and Corporate Governance Committee	Resigned	2022-09-24	2022-09-29
John Bolger	member of the Board	Resigned	2022-09-24	2022-09-29
Yun Yen, M.D., Ph.D., F.A.C.P.	Board of Directors (and Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee of the Board)	Resigned	2022-06-25	2022-06-30

Key facts CIK 1674930 CUSIP 359664109 13F (30d) 132 filings 128 filers Visit website Investor relations